FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3013671632> ?p ?o ?g. }

• W3013671632 abstract "Abstract Background Women with breast cancer experience a significantly higher prevalence of sleep disturbance and insomnia than the general population. The experience of persistent sleep disturbance places these women at a higher risk of psychological and physical morbidity and a reduced quality of life. Treatment for sleep in this population is not part of routine care and is often managed inadequately. This randomised controlled trial will examine the combined effects of cognitive behavioural therapy (CBT) and bright light therapy (BLT) on the symptoms of insomnia, fatigue and mental health. Method/design Women diagnosed with breast cancer who receive intravenous chemotherapy treatment at a quaternary referral metropolitan cancer centre in Melbourne, Australia, will be recruited. Recruitment will occur after diagnosis and prior to completion of chemotherapy. Eligible women will be randomised to the combined CBT and BLT intervention (CBT+) or relaxation audio-enhanced treatment as usual (TAU+). The CBT+ group will receive one face-to-face session on sleep strategies, one subsequent telephone call, and seven email packages containing CBT-based information and strategies. CBT+ participants will also wear Luminette® light glasses for 20 min each morning for the 6-week duration of the intervention. Women in TAU+ will receive two relaxation audio tracks via email. Outcomes will be measured at multiple points throughout the 6 weeks. Primary outcomes will be symptoms of insomnia and sleep efficiency, measured using the Insomnia Severity Index and a self-reported sleep diary. Secondary outcomes include objective measures of sleep assessed using the ActiGraph wGT3X-BT, and sleep-related complaints, fatigue and mental health, all assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS). Data will also be collected on potential treatment moderators and mechanisms and adherence to treatment. There will be 3-month follow-up measurements of insomnia symptoms, fatigue, sleep-related impairment, sleep disturbance, depression and anxiety. Discussion This is the first randomised controlled trial to combine CBT and BLT for the treatment of sleep disturbance in women with breast cancer. This novel design addresses the multiple causal factors for sleep complaints in this population. Results from this trial will advance knowledge in this field and may have important clinical implications for how best to treat sleep disturbance and insomnia in this population. If effective, the largely email-based format of the intervention would allow for relatively easy translation. Trial Registration Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12618001255279 . Retrospectively registered on 25 July 2018." @default.
• W3013671632 created "2020-04-03" @default.
• W3013671632 creator A5002544295 @default.
• W3013671632 creator A5002932877 @default.
• W3013671632 creator A5006984473 @default.
• W3013671632 creator A5009657358 @default.
• W3013671632 creator A5010427980 @default.
• W3013671632 creator A5023821986 @default.
• W3013671632 creator A5027201197 @default.
• W3013671632 creator A5034518111 @default.
• W3013671632 creator A5038596064 @default.
• W3013671632 date "2020-03-27" @default.
• W3013671632 modified "2023-10-14" @default.
• W3013671632 title "Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer" @default.
• W3013671632 cites W142672915 @default.
• W3013671632 cites W1440215996 @default.
• W3013671632 cites W1519947679 @default.
• W3013671632 cites W1554453654 @default.
• W3013671632 cites W1571066563 @default.
• W3013671632 cites W1574691271 @default.
• W3013671632 cites W1696447131 @default.
• W3013671632 cites W1755933041 @default.
• W3013671632 cites W1824554907 @default.
• W3013671632 cites W1865957711 @default.
• W3013671632 cites W1970526131 @default.
• W3013671632 cites W1971153042 @default.
• W3013671632 cites W1972519049 @default.
• W3013671632 cites W1982292101 @default.
• W3013671632 cites W1983252826 @default.
• W3013671632 cites W1985564128 @default.
• W3013671632 cites W2000712271 @default.
• W3013671632 cites W2002264690 @default.
• W3013671632 cites W2012435382 @default.
• W3013671632 cites W2017152382 @default.
• W3013671632 cites W2017514184 @default.
• W3013671632 cites W2023212883 @default.
• W3013671632 cites W2029057559 @default.
• W3013671632 cites W2030884426 @default.
• W3013671632 cites W2034331567 @default.
• W3013671632 cites W2037678947 @default.
• W3013671632 cites W2041749697 @default.
• W3013671632 cites W2045091609 @default.
• W3013671632 cites W2048458454 @default.
• W3013671632 cites W2053601856 @default.
• W3013671632 cites W2057798107 @default.
• W3013671632 cites W2060806732 @default.
• W3013671632 cites W2061393918 @default.
• W3013671632 cites W2062152247 @default.
• W3013671632 cites W2063069706 @default.
• W3013671632 cites W2066358461 @default.
• W3013671632 cites W2080940402 @default.
• W3013671632 cites W2081402562 @default.
• W3013671632 cites W2082850379 @default.
• W3013671632 cites W2083495357 @default.
• W3013671632 cites W2086389767 @default.
• W3013671632 cites W2092938587 @default.
• W3013671632 cites W2107212157 @default.
• W3013671632 cites W2107434300 @default.
• W3013671632 cites W2110108956 @default.
• W3013671632 cites W2111180320 @default.
• W3013671632 cites W2114486723 @default.
• W3013671632 cites W2131593307 @default.
• W3013671632 cites W2132331779 @default.
• W3013671632 cites W2140681667 @default.
• W3013671632 cites W2145555293 @default.
• W3013671632 cites W2145603964 @default.
• W3013671632 cites W2148326401 @default.
• W3013671632 cites W2154692973 @default.
• W3013671632 cites W2156685827 @default.
• W3013671632 cites W2157030933 @default.
• W3013671632 cites W2159516675 @default.
• W3013671632 cites W2161493662 @default.
• W3013671632 cites W2289810507 @default.
• W3013671632 cites W2341700042 @default.
• W3013671632 cites W2465205246 @default.
• W3013671632 cites W2521914513 @default.
• W3013671632 cites W2560982240 @default.
• W3013671632 cites W2607414282 @default.
• W3013671632 cites W2767313877 @default.
• W3013671632 cites W2782908833 @default.
• W3013671632 cites W2783852654 @default.
• W3013671632 cites W2793036539 @default.
• W3013671632 cites W2794770411 @default.
• W3013671632 cites W2795183976 @default.
• W3013671632 cites W2883488605 @default.
• W3013671632 cites W2897690276 @default.
• W3013671632 cites W2972485842 @default.
• W3013671632 cites W4247665917 @default.
• W3013671632 doi "https://doi.org/10.1186/s13063-020-4196-4" @default.
• W3013671632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7099834" @default.
• W3013671632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32216832" @default.
• W3013671632 hasPublicationYear "2020" @default.
• W3013671632 type Work @default.
• W3013671632 sameAs 3013671632 @default.
• W3013671632 citedByCount "13" @default.
• W3013671632 countsByYear W30136716322020 @default.
• W3013671632 countsByYear W30136716322021 @default.
• W3013671632 countsByYear W30136716322022 @default.
• W3013671632 crossrefType "journal-article" @default.
• W3013671632 hasAuthorship W3013671632A5002544295 @default.

• next